date,title,source
Oct-24-18,"Market Trends Toward New Normal in UROGEN PHARMA, Cimarex Energy, Boingo Wireless, TransCanada, EXTRACTION O&G, and ACADIA Pharmaceuticals  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-30-18,FDA Grants Breakthrough Therapy Designation (BTD) for UroGen Pharmas UGN-101 for the Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer (LG UTUC),Business Wire
